Insider Trading & Ownership - English Emily

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for English Emily
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2025-01-03
Sale
2025-01-07
8:05 pm
Cartesian Therapeutics Inc.RNACEnglish Emily
Chief Operations Officer
1,797$16.78$30,14940,226
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-05-12
Exercise
2025-05-14
4:15 pm
N/A
N/A
Cartesian Therapeutics Inc.RNACEnglish Emily
Chief Operations Officer
7,500$3.389,595
(Direct)
View
2025-05-12
Exercise
2025-05-14
4:15 pm
N/A
2031-04-25
Cartesian Therapeutics Inc.RNACEnglish Emily
Chief Operations Officer
7,500$089,595
(Direct)
View
2025-04-15
Exercise
2025-04-16
4:35 pm
N/A
N/A
Cartesian Therapeutics Inc.RNACEnglish Emily
Chief Operations Officer
7,500$3.389,595
(Direct)
View
2025-04-15
Exercise
2025-04-16
4:35 pm
N/A
2031-04-25
Cartesian Therapeutics Inc.RNACEnglish Emily
Chief Operations Officer
7,500$089,595
(Direct)
View
2025-01-02
Option Award
2025-01-06
4:21 pm
N/A
2035-01-01
Cartesian Therapeutics Inc.RNACEnglish Emily
Chief Operations Officer
63,500$089,423
(Direct)
View
2024-12-26
Exercise
2024-12-30
4:11 pm
N/A
N/A
Cartesian Therapeutics Inc.RNACEnglish Emily
SVP, Head of Manufacturing
7,650$3.375,292
(Direct)
View
2024-12-26
Exercise
2024-12-30
4:11 pm
N/A
2031-04-25
Cartesian Therapeutics Inc.RNACEnglish Emily
SVP, Head of Manufacturing
7,650$075,292
(Direct)
View

Ownership
2024-04-19
4:49 pm
N/A
N/A
Cartesian Therapeutics Inc.RNACEnglish Emily
SVP, Head of Manufacturing
0$0112,979
(Direct)
View